Year: 2026
Type: preprint
Abstract: Fibrosis develops in many organs through different initiating injuries, yet repeatedly engages inflammation, stromal activation and extracellular-matrix remodelling. Whether these recurring features represent a conserved disease programme, and whether commonly used mouse models reproduce it, remain unresolved. We developed ScarX, an R/Shiny workflow that analyses organ-resolved bulk RNA sequencing, identifies directional overlap across tissues, and ranks human-mouse conserved signals while retaining organ-restricted results. Public RNA-sequencing datasets representing fibrotic or fibrosis-associated disease in human heart, kidney, liver and lung were compared with matched mouse injury models. Differential expression was estimated independently within each organ using DESeq2, followed by cross-organ intersection, functional enrichment, matched-organ effect-profile comparison and a human-first conserved modulation (HCM) score that gives greatest weight to the breadth and magnitude of human disease change, adds support for same-direction mouse effects and penalises discordance. In human disease, 202 genes increased and 35 decreased in the same direction across all four organs. Mouse models contained 409 pan-organ increases and 46 decreases. After gene-symbol harmonisation, 25 gene-direction signatures were conserved across all four organs in both species. These included AEBP1 , CDH11 , COL1A1 , COL1A2 , COL3A1 , COL5A2 , COL6A2 , EFEMP2 , EMILIN1 , LOXL1 , LOXL2 , TGFB2 and VIM . Matched human-mouse effect profiles varied considerably: Spearman rho was 0.42 for kidney, 0.31 for heart, 0.16 for liver and -0.06 for lung. Despite this uneven gene-level fidelity, 62 same-direction pathways were shared across species, led by extracellular-matrix organisation, collagen fibril organisation, cell-substrate adhesion, wound healing and ECM-receptor interaction. The HCM ranking concentrated structural matrix genes near the top but also identified cell-surface, secreted and regulatory candidates. Among the top 500 candidates, 376 carried at least one local tractability annotation. ScarX therefore separates a compact conserved matrix-remodelling core from a much larger organ- and species-dependent response. The results provide a transparent starting point for target and biomarker selection, while also showing why expression conservation alone cannot establish therapeutic dependence.
Institutions: Centre for Inflammation Research, University of Edinburgh
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Award: G3731320440
OpenAlex ID: W7233914498
